[8-K] Cushman & Wakefield plc Reports Material Event

Rhea-AI Filing Summary

Axogen, Inc. (AXGN) filed a Form 8-K dated 5 Aug 2025 to furnish materials related to its second-quarter 2025 results.

Under Item 2.02, the company issued an earnings press release (Exhibit 99.1). Under Item 7.01, it posted a corresponding investor presentation (Exhibit 99.2) to its IR website. Both exhibits are being furnished, not filed, so they are excluded from Section 18 liability and will not be incorporated into future SEC filings unless expressly stated. No quantitative financial data is included in the 8-K itself, and there are no other material transactions or governance changes disclosed.

Insights

Financial Analyst

TL;DR: Routine 8-K furnishes Q2 results materials; no numbers disclosed, neutral impact.

The filing simply alerts investors that Axogen has released its Q2 2025 earnings press release and an investor deck. Because the exhibits are only furnished, investors must consult the attachments or company website for financial details. The absence of embedded metrics means the 8-K itself does not change the valuation narrative; its importance hinges on the yet-unseen results. Overall, this is a standard disclosure with negligible immediate market impact.

Securities Lawyer

TL;DR: Standard compliance filing; no Section 18 liability, low litigation risk.

Axogen properly used Items 2.02 and 7.01 to furnish—not file—its press release and presentation, thereby limiting potential Exchange Act liability. The company also provided Inline XBRL cover data (Ex104) as required. No new commitments, material agreements, or forward-looking guidance were embedded in the body of the report. From a governance and compliance perspective, this is a textbook, low-risk event.

0001628369false00016283692025-08-052025-08-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________________

FORM 8-K

_____________________________

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 5, 2025

_____________________________

Cushman & Wakefield plc

(Exact name of registrant as specified in its charter)

_____________________________

England and Wales			001-38611			98-1193584
(State or other jurisdiction of incorporation)			(Commission File Number)			(IRS Employer Identification No.)
			125 Old Broad Street
			London, United Kingdom, EC2N 1AR
			(Address of principal executive offices) (Zip Code)
			+44 20 3296 3000
			(Registrant’s telephone number, including area code)
			Not applicable
			(Former name or former address, if changed since last report)

_____________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12(b))

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Ordinary Shares, $0.10 nominal value			CWK			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   

Item 2.02  Results of Operations and Financial Condition.

On August 5, 2025, Cushman & Wakefield plc issued a press release reporting its financial results for the second quarter of 2025. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Item 2.02, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01  Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.			Description
99.1 *			Press Release of Financial Results for the Second Quarter 2025
104			Cover Page Interactive Data File (formatted as Inline XBRL)

* Furnished herewith.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CUSHMAN & WAKEFIELD PLC

Date: August 5, 2025

/s/ Laurida Sayed

Laurida Sayed

Chief Accounting Officer

FAQ

Why did Axogen (AXGN) file this Form 8-K on August 5, 2025?

To furnish its Q2 2025 earnings press release (Ex 99.1) and investor presentation (Ex 99.2) under Items 2.02 and 7.01.

Are the Q2 2025 financial numbers included in this 8-K filing?

No. The filing references the press release and presentation, but the numeric results are in the exhibits, not in the body of the report.

Are Exhibits 99.1 and 99.2 considered "filed" with the SEC?

No. They are "furnished" and therefore not subject to Section 18 liability unless later incorporated by reference.

Where can investors access the Q2 2025 presentation?

It is available on Axogen’s investor relations site at https://ir.axogeninc.com/news-events and attached as Exhibit 99.2.

Does the 8-K disclose any other material events or transactions?

No. The report solely covers the release of Q2 2025 results materials; no additional transactions or leadership changes are mentioned.